Johnson & Johnson Pauses Phase 3 COVID-19 Vaccine Trial Following ‘Unexplained Illness’
Story Highlights Weeks after Johnson & Johnson announced that their experimental COVID-19 vaccine was in final, Phase 3 testing, the company has paused the study to evaluate an unexplained illness in a study participant. AstraZeneca’s late-stage vaccine trial is also still on pause in the U.S. after two cases of a neurological illness arose in […]
What Does Zinc Bring to the Table?
Story Highlights Zinc is a trace element necessary for human health and has many important benefits including anti-inflammatory properties and powerful immune system support. It has long been used to reduce the duration and severity of the common cold, which is generally caused by coronaviruses. Zinc is not made by or stored in the body […]
Only Half of Americans Polled Say They Would Get COVID-19 Vaccine
In a poll conducted for CNN during Oct. 1-4, 2020, the Pennsylvania-based market research firm SSRS found that 51 percent of the 1,205 Americans surveyed said they would try to get a COVID-19 vaccine if it were widely available at a low cost, 45 percent said they would not and four percent had no opinion. Sixty […]
Honeybee Venom Destroys Cancer Cells
Story Highlights Honeybee venom has been previously studied for its potential benefits in the treatment of arthritis, rheumatism, pain relief, and cancerous tumors among other conditions, but the mechanism by which it works has not been clear. Australian scientists have published a paper with evidence for the ability of honeybee venom to rapidly and selectively […]
Polls Find Many Americans Do Not Want COVID-19 Vaccine as Soon as It’s Licensed
Story Highlights More adults in the U.S. are expressing doubts about the safety of a newly licensed COVID-19 vaccine that might become available this year. The number of poll respondents planning on getting a new coronavirus vaccine as soon as it is FDA approved has fallen from a reported high of 50 to 60 percent […]
The T-Cell Response to COVID-19 Infections and Immunity
Story Highlights Rapid decline of neutralizing antibodies following COVID-19 infection in some people have led to concerns that immunity to the SARS-CoV-2 virus Is temporary. However, several recent studies have shown a presence of virus-specific T-cells that remain, including among patients with mild or asymptomatic infections. Long-lasting immunity after recovery from COVID-19 infection may be […]
